Paul B Manning
CIK 1494695 · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$129.94M
Companies
7
Total Filings
71
Lifetime Open-Market Net
$75.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 667,996 | $71.23 | $47.58M | -$24.24M | 15 | 2026-06-08 |
| CADL | Director | 2,984,752 | $8.56 | $25.55M | $23.91M | 11 | 2026-04-02 |
| VRCA | Director | 7,306,561 | $5.73 | $41.87M | $48.04M | 17 | 2025-11-25 |
| TSHA | Director | 1,355,333 | $5.71 | $7.74M | $25.15M | 13 | 2025-06-03 |
| ABOS | 10%+ Owner | 3,040,193 | $2.37 | $7.21M | $5.00M | 1 | 2021-07-08 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | Director | 0 | — | — | $7.34M | 8 | 2019-11-12 |
| AveXis, Inc. (AVXS) Delisted | Director | 0 | — | — | -$10.00M | 6 | 2018-05-15 |
Recent Filings · Page 7 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-08-14 | VRCA | Buy (P) | +33,000 | $497.6K | EDGAR |
| 2018-06-19 | VRCA | Conv (C) | +9,144,317 | $0 | EDGAR |
| 2018-06-08 | Dova Pharmaceuticals Inc. (DOVA) Delisted | Buy (P) | +27,000 | $767.4K | EDGAR |
| 2018-06-06 | Dova Pharmaceuticals Inc. (DOVA) Delisted | Buy (P) | +120,000 | $3.14M | EDGAR |
| 2018-05-15 | AveXis, Inc. (AVXS) Delisted | Disp (D) | −1,455,205 | $0 | EDGAR |
| 2018-03-30 | AveXis, Inc. (AVXS) Delisted | Grant (A) | +1,106 | $0 | EDGAR |
| 2017-11-13 | Dova Pharmaceuticals Inc. (DOVA) Delisted | Other (J) | — | $0 | EDGAR |
| 2017-06-01 | AveXis, Inc. (AVXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-15 | AveXis, Inc. (AVXS) Delisted | Sell (S) | −289,855 | -$10.00M | EDGAR |
| 2016-02-19 | AveXis, Inc. (AVXS) Delisted | Conv (C) | +3,337,294 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.